Is AVNT a buy according to AI stock analysis?

AVNT AI stock analysis does not label the stock as an automatic buy. It shows a cyclical value with improving earnings, a cheap forward multiple near 12x, a Buy analyst consensus at $47.14, and a 2.97% dividend yield, but a $1.5 billion net debt load means the outcome still depends on packaging demand, raw material costs, and back-half execution.

What is the AVNT AI stock forecast?

The AVNT AI stock forecast is scenario-based around the $37.23 quote: a bullish range of $44 to $52, a base range of $37 to $47, and a bearish range of $28 to $34. These ranges depend on packaging and healthcare demand, electronics growth, raw material inflation from the Middle East conflict, and the forward multiple, and they are scenarios, not promises.

What technical levels matter for AVNT?

The main AVNT technical levels are support near $35 to $36.30, which includes the 200-day moving average near $35.07, next support near $32 to $33, and resistance near $40 to $44.85, which includes the 52-week high. A close below $35 would break the recovery structure.

Can AI predict AVNT stock price?

No, AI cannot reliably predict stock prices. AI can organize data, compare scenarios, flag specialty polymer cycle risks, and build trading rules, but AVNT can move on raw material costs, Middle East supply disruption, earnings on August 6, 2026, end-market demand, and macro factors after the data cutoff.

How should I use this AVNT AI trading strategy?

Use this AVNT AI trading strategy as a research checklist, not as personal advice. Confirm live price data and moving averages, review the Q2 2026 earnings report and fresh filings, define your risk, and decide whether the setup fits your time horizon and loss limits.

What is Avient business in one paragraph?

Avient is a specialty polymer materials company with two segments. Color, Additives and Inks is the larger segment and sells custom color and additive concentrates, dispersions, and specialty inks for thermoplastics and thermosets, while Specialty Engineered Materials sells advanced composites, engineered materials, and functional additives. Packaging is the largest end market at about 23% of revenue, followed by healthcare, building and construction, consumer, defense, and industrial applications.

Why did AVNT recover from its 52-week low?

AVNT traded at $37.23 during the August 3, 2026 session, about 35.5% above the 52-week low of $27.48, helped by a Q1 2026 adjusted EPS beat, adjusted EBITDA margin expansion to 17.7%, management guidance for greater than $200 million of 2026 free cash flow, a Buy analyst consensus, and a pickup in the packaging end market.

What is the biggest risk in AVNT AI stock analysis?

The biggest AVNT risk is that raw material inflation from the Middle East conflict compresses margins faster than price recovery, or that Q2 pre-buying pulls demand forward and leaves a soft back half, while the $1.5 billion net debt load and a debt-to-EBITDA near 3.95x limit balance sheet flexibility if consumer and industrial demand keep falling.

Avient Corporation research snapshot

AVNT AI Stock Analysis

AVNT AI stock analysis as of the August 4, 2026 data cutoff reads Avient Corporation as a specialty polymer materials company whose earnings recovery, cheap forward multiple, and Buy analyst consensus are now the main bullish hooks, while the balance sheet still carries meaningful debt. The stock traded at $37.23 during the August 3, 2026 session, up about 35.5% from the 52-week low of $27.48 but still about 17% below the 52-week high of $44.85, with a market capitalization near $3.41 billion verified as $37.23 times 91.71 million shares outstanding. TTM revenue is about $3.28 billion with net income of $157.8 million, and management beat its own Q1 2026 adjusted EPS guidance of $0.81 by delivering $0.83 while expanding adjusted EBITDA margins by 20 basis points to 17.7%. The stock trades at roughly 21.6x trailing earnings but only about 12x the FY2026 adjusted EPS consensus of $3.07, with a 2.97% dividend yield. The main debate is whether the demand recovery in packaging and the electronics and high performance computing growth vector can offset continued weakness in consumer and industrial end markets and raw material inflation linked to the Middle East conflict. Q2 2026 earnings are scheduled for August 6, 2026. This page uses scenario ranges and source checks, not a certain stock price prediction, and is informational only, not investment advice.

Current price

$37.23 during the August 3, 2026 session, up 2.51% on the day; Q2 2026 earnings scheduled for August 6, 2026

Market cap

$3.41 billion

AI score

56 / 100

Rating

Cyclical value improving, Buy consensus, elevated debt

Trend status

Recovering, above the 200-day moving average near $35.07, below the 52-week high of $44.85

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness: B-level information richness. Avient has over two decades of public filings, a Q1 2026 earnings release and full call transcript, and coverage from 7 sell-side firms including Truist, Seaport Global, Wells Fargo, Oppenheimer, Morgan Stanley, Baird, and KeyBanc. Some segment-level detail still requires inference from annual reports.
bias Check: The main AI bias risk is anchoring on the Q1 2026 adjusted EPS beat and the packaging demand pickup as a confirmed inflection, when consumer and industrial demand remain soft and volumes were down about 2% in Q1. The reverse check asks whether a forward multiple near 12x properly reflects the $1.5 billion net debt load, debt-to-EBITDA near 3.95x, and the possibility that Q2 pre-buying pulls demand forward from the back half of the year.
ai Confidence: High for verified market cap, share count, P/E, forward P/E, revenue, free cash flow, balance sheet, and point-in-time quote calculations that matched across StockAnalysis.com, Barchart, and the Q1 2026 earnings release. Medium for forward estimates and scenario ranges because specialty polymer earnings depend on raw material costs, Middle East supply chain disruption, end-market demand, and debt service costs.
investment Certainty: Medium-low. Avient has an understandable business model, a strengthening packaging franchise, and a more attractive forward multiple than a year ago, but the stock at about 12x forward adjusted EPS with roughly $1.5 billion net debt and an Altman Z-score of 1.87 leaves a moderate margin of safety that still depends on cyclical execution. Investment certainty is lower than data confidence because balance sheet leverage and second-half macro uncertainty reduce the margin for error.

Quick verdict table

Dimension	Conclusion	Confidence
Business quality	Avient formulates specialty polymer colorants, additives, inks, and engineered materials sold to packaging, healthcare, building and construction, consumer, defense, and industrial end markets globally across the Color, Additives and Inks and Specialty Engineered Materials segments.	Medium
Moat	Moat comes from customer formulation lock-in, regulatory and food contact certifications, a local service model, and a global manufacturing footprint. Less than 5% of agreements are price indexed, which helped Avient stay net price positive through prior inflation cycles, but switching costs are moderate rather than impenetrable.	Medium
Management	Dr. Ashish Khandpur is Chairman, President and CEO. CFO leadership changed in June 2026, with Joe Di Salvo promoted after Jamie Beggs departed, and management emphasized cash generation, debt reduction, productivity, and a greater than $200 million 2026 free cash flow target on the Q1 2026 call.	Medium
Financial trend	TTM revenue is about $3.28 billion, up about 1.3%, with net income of $157.8 million, up 58%, and EPS of $1.72, up about 59%. Q1 2026 adjusted EPS of $0.83 beat the $0.81 guidance and grew 9% year over year with adjusted EBITDA margins up 20 basis points to 17.7%.	Medium-high
Valuation	At about 21.6x trailing earnings, 11.95x forward earnings, an EV/EBITDA near 10.1x, and a 2.97% dividend yield, AVNT trades at a mid-cycle specialty chemicals valuation with a Buy consensus target of $47.14 implying about 27% upside from the $37.23 quote.	Medium-low
Technical trend	The stock is recovering and sits above its 200-day moving average near $35.07 and its 50-day near $36.33, but momentum is neutral with a 14-day RSI near 51.9 and low ADX, and resistance near the $40 to $45 zone still needs volume confirmation to break.	Medium
Risk level	The thesis can fail if raw material inflation from the Middle East conflict compresses margins, consumer and industrial demand stay weak, customers pull forward demand and leave a soft back half, debt service costs rise, or the 3.95x debt-to-EBITDA balance sheet limits flexibility.	Medium-high
AI confidence	High data confidence for point-in-time metrics, quote verification, Q1 2026 results, guidance, balance sheet, and analyst consensus that matched across sources. Lower confidence for forward returns given specialty polymer cyclicality and balance sheet leverage.	High data confidence
Investment certainty	Medium-low certainty because this page provides a research framework and scenario ranges, not a personalized buy or sell decision, and the second half of 2026 carries elevated macro uncertainty.	Medium-low

AVNT AI stock forecast

AVNT AI Stock Forecast Scenarios

The AVNT AI stock forecast uses scenario ranges around the $37.23 quote rather than a point target. The one-year scenario model applies growth of 12%, 6%, and negative 3% to the FY2026 adjusted EPS consensus of $3.07 with exit multiples of 15x, 12x, and 10x, producing a bearish area near $30, a base area near $39, and a bullish area near $52. These are scenarios, not price promises.

Bullish case

$44 to $52

More likely if packaging and healthcare demand hold, the electronics and high performance computing growth vector keeps expanding, consumer and industrial end markets recover, management executes the greater than $200 million free cash flow plan and reduces debt, and the stock moves toward the $47.14 consensus and the $52 Morgan Stanley target with volume confirmation above the 52-week high of $44.85.

Base case

$37 to $47

More likely if Avient delivers FY2026 adjusted EPS in the $2.93 to $3.17 guidance range with adjusted EBITDA of $555 million to $585 million, price and mix drive low single-digit organic growth, and the stock trades near the $47.14 analyst average target at a forward multiple closer to 14x to 15x.

Bearish case

$28 to $34

More likely if raw material cost inflation from the Middle East conflict compresses margins, Q2 pre-buying pulls demand forward and weakens the back half, consumer and industrial demand keep falling, or the forward multiple compresses toward 10x on softer earnings, bringing the stock back toward the $30 area and below the 200-day moving average.

AVNT AI technical analysis

AVNT AI Technical Analysis

AVNT AI technical analysis starts from the $37.23 August 3, 2026 session quote. The stock is in a recovery within a longer range, trading above its 200-day moving average near $35.07 and its 50-day near $36.33, with a neutral 14-day RSI near 51.9. Because this static page does not fetch request-time chart data, moving averages and momentum should be confirmed in a charting tool before use.

Level	Value	Why it matters
Current price	$37.23	August 3, 2026 session quote, up 2.51% on the day with a previous close of $36.32.
Near support	$35 to $36.30	The 50-day moving average near $36.33 and the 200-day near $35.07 form the first support zone that the recovery has been holding above.
Next support	$32 to $33	The prior consolidation low area near $32 to $33 is the next downside reference if the 200-day moving average fails.
Near resistance	$40 to $44.85	The $40 round level is the first hurdle, and the 52-week high of $44.85 is the major resistance zone. A close above $40 with volume could confirm a trend reversal.
50-day moving average	$36.33	Barchart reported the 50-day near $36.33 and StockAnalysis.com near $36.34 on August 3, 2026, below the current price and consistent with an improving short-term trend.
200-day moving average	$35.07	StockAnalysis.com and Barchart both reported the 200-day trend line near $35.07, and the stock holds above it, which defines the longer-term recovery structure.
Momentum	RSI near 51.9, ADX near 9.3	The 14-day RSI near 51.9 is neutral and the 14-day ADX near 9.3 indicates a range rather than a strong directional trend, so confirmation from volume and price is needed.
Volume	About 709,000 to 718,000 average shares	StockAnalysis.com reported 20-day average volume near 708,968 and Barchart near 718,412, so breakout signals should be judged against this baseline.
Volatility	Moderate to high monitoring priority (beta 1.28)	Barchart reported 14-day historic volatility near 42% and StockAnalysis.com a five-year beta of 1.28, so position sizing should tolerate wide daily movement.
Invalidation	Close below $35	A decisive close below the $35 support zone, which is also the 200-day moving average, would break the recovery structure and could open a re-test of the $32 to $33 zone and the 52-week low.

AVNT AI trading strategy

AVNT AI Trading Strategy Framework

The AVNT AI trading strategy is a rules-based research framework. It is not personalized advice and should be paired with position sizing, stop levels, the August 6, 2026 Q2 earnings report, and checks of fresh filings and specialty polymer cycle indicators.

Trend-following setup

Wait for AVNT to hold above the $35 to $36.30 support zone and confirm a push through $40 with above-average volume before initiating a long position, with the 52-week high near $44.85 as the next objective.

A close below $35 or a failure to break resistance with volume should invalidate the setup, because the recovery structure depends on the stock staying above the 200-day moving average.

Mean-reversion setup

If AVNT pulls back toward the $35 to $36.30 zone without a fundamental thesis break, compare the price reaction with the August 6, 2026 earnings report, packaging and healthcare demand commentary, and raw material cost trends before acting.

Do not average down without a predefined maximum loss and a fresh review of end-market demand, Middle East raw material inflation, and debt reduction progress, because a support zone can break if the back half weakens.

Fundamental monitor

Track the evidence that matters most for specialty polymers: packaging and healthcare end-market growth, electronics and high performance computing sales, adjusted EBITDA margin trajectory, debt-to-EBITDA reduction, free cash flow conversion toward the greater than $200 million 2026 target, and management execution.

Reduce confidence when price moves are driven by raw material speculation or Q2 pre-buying without matching evidence in end-market demand or margin improvement.

Investment research summary

Four-master Research Compression

Business essence

Avient formulates and sells specialty polymer colorants, additives, inks, and engineered materials to manufacturers in packaging, healthcare, building and construction, consumer, defense, and industrial end markets globally. Customers pay for the speed of material qualification, local technical service, and certified supply.

Moat

The moat comes from customer formulation lock-in, regulatory and food contact certifications, a local service model with a global footprint, and a pricing model where less than 5% of agreements are indexed, which allowed Avient to stay net price positive through the 2021 to 2022 and 2025 inflation episodes.

Munger risk inversion

The thesis can fail if Middle East conflict drives raw material inflation that compresses margins faster than price, consumer and industrial demand keep falling, Q2 pre-buying pulls demand forward and weakens the back half, or debt service costs pressure free cash flow given the $1.5 billion net debt load.

Management

CEO Dr. Ashish Khandpur has emphasized productivity, debt reduction, and growth vectors. CFO leadership transitioned in June 2026 to Joe Di Salvo, and the Q1 2026 call highlighted a greater than $200 million free cash flow target and a maintained 2026 guidance of $555 million to $585 million adjusted EBITDA and $2.93 to $3.17 adjusted EPS.

Industry trend

Specialty chemicals is a cyclical but resilient industry benefiting from long-term plastics substitution, regulatory-driven specialty formulations, and a new electronics and high performance computing growth vector that management expects to exceed $40 million in 2026 sales after doubling in three years.

Valuation and margin of safety

At about 11.95x forward earnings and an EV/EBITDA near 10.1x, AVNT is cheaper than a year ago and the 2.97% dividend yield adds a return component. The Buy consensus target of $47.14 implies about 27% upside, but the $1.5 billion net debt load and Altman Z-score of 1.87 mean the margin of safety still depends on cyclical execution.

Source-backed data

AVNT Data Table

Every metric below includes a source and last verification date.

Metric	Value	Source	Last verified
AVNT price	$37.23 during the August 3, 2026 session, up $0.91 or 2.51%, with a previous close of $36.32	StockAnalysis.com real-time quote (CBOE)	August 3, 2026
Market capitalization	$3.41 billion, computed as $37.23 x 91.71 million shares outstanding	StockAnalysis.com quote and financial_rigor.py verification passed with 0.13% deviation	August 3, 2026
Exchange	NYSE	StockAnalysis.com company profile	August 3, 2026
Enterprise value	$4.92 billion	StockAnalysis.com statistics	August 3, 2026
Revenue (TTM)	$3.28 billion, up about 1.3%, with FY2025 revenue of $3.26 billion up 0.61%	StockAnalysis.com financials	August 3, 2026
Net income (TTM)	$157.8 million, up 58%, with EPS of $1.72, up about 59%	StockAnalysis.com statistics	August 3, 2026
EBITDA (TTM)	$487.1 million	StockAnalysis.com statistics	August 3, 2026
Valuation check	Trailing PE of 21.59, forward PE of 11.95, PS of 1.04, PB of 1.38, P/FCF of 16.68, EV/EBITDA of 10.10	StockAnalysis.com statistics	August 3, 2026
Q1 2026 sales	$847 million, up 3% year over year including a 5% favorable foreign exchange impact	Avient Q1 2026 earnings release	May 7, 2026
Q1 2026 adjusted EPS	$0.83, ahead of the $0.81 guidance and up 9% from $0.76 in the prior year quarter	Avient Q1 2026 earnings release	May 7, 2026
Q1 2026 adjusted EBITDA margin	17.7%, up 20 basis points year over year	Avient Q1 2026 earnings release	May 7, 2026
2026 guidance	Adjusted EBITDA of $555 million to $585 million and adjusted EPS of $2.93 to $3.17, maintained, with Q2 2026 adjusted EPS guidance of $0.89, up 11%	Avient Q1 2026 earnings release and call	May 7, 2026
2026 free cash flow guidance	Greater than $200 million expected in 2026	Avient Q1 2026 earnings call	May 7, 2026
Free cash flow (TTM)	Operating cash flow of $318.2 million, capital expenditures of $113.1 million, free cash flow of $205.1 million	StockAnalysis.com cash flow statement	August 3, 2026
Cash and debt	Cash and equivalents of $427.6 million, total debt of $1.92 billion, and net debt of about $1.50 billion or $16.32 per share as of March 31, 2026	StockAnalysis.com balance sheet	August 3, 2026
Segment revenue (TTM)	Color, Additives and Inks of about $2.04 billion and Specialty Engineered Materials of about $1.24 billion as of the March 31, 2026 quarter	StockAnalysis.com financial metrics	August 3, 2026
Dividend	Annual dividend of $1.10, yield of 2.97%, quarterly dividend of $0.275, ex-dividend date September 11, 2026, payable October 7, 2026, with 14 years of dividend growth	StockAnalysis.com dividend page and Avient dividend release	July 16, 2026
Analyst consensus	Buy with an average price target of $47.14 across 7 analysts, low $42 and high $52, median $47, implying about 27% upside	StockAnalysis.com forecast	June 8, 2026
Recent analyst updates	Truist initiated Buy with a $44 target on June 8, 2026; Seaport Global Buy at $50 on June 7, 2026; Wells Fargo Buy at $47 on June 5, 2026; Oppenheimer Buy at $47 on May 8, 2026; Baird lowered to $43 from $46 on May 8, 2026	StockAnalysis.com forecast and analyst updates	June 8, 2026
FY2026 and FY2027 consensus estimates	FY2026 revenue estimate of $3.38 billion with adjusted EPS of $3.07, FY2027 revenue of $3.50 billion with adjusted EPS of $3.38	StockAnalysis.com forecast	June 8, 2026
52-week range and performance	52-week range of $27.48 to $44.85, up about 10.3% over the trailing 52 weeks and up about 18.6% year to date, beta of 1.28	StockAnalysis.com quote and statistics	August 3, 2026
Technical snapshot	50-day moving average near $36.33, 200-day near $35.07, 14-day RSI near 51.9, 14-day ADX near 9.3, 14-day historic volatility near 42%	Barchart technical analysis and StockAnalysis.com statistics	August 3, 2026
Short interest	4.25 million shares short, 4.63% of shares outstanding, about 4.0 days to cover	StockAnalysis.com statistics	August 3, 2026
Balance sheet health	Debt to equity of 0.80, debt to EBITDA of 3.95, interest coverage of 3.22, Altman Z-score of 1.87, Piotroski F-score of 7	StockAnalysis.com statistics	August 3, 2026
Next earnings date	Q2 2026 results scheduled for Thursday, August 6, 2026 before market open	Avient Q2 2026 conference call announcement and StockAnalysis.com	July 7, 2026

Frequently Asked Questions

Read the SXT AI stock analysis View the EMN AI stock analysis Explore the ALB AI stock forecast Compare ideas in AI Stock Picker Build a rules-based trading strategy Run an AI stock screener

This AVNT AI stock analysis page is an informational tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of the August 4, 2026 data cutoff, may be incomplete, and can be wrong if the Q2 2026 earnings report on August 6, 2026, new filings, market prices, Middle East supply conditions, or macro conditions change.